KRAS and familial pancreatic carcinoma: While the single agent BMS833923 was not effective in suppression of pancreatic cancer metastasis, it is still possible that combining hedgehog signaling inhibition with reduction of K-RAS signaling, the major driver for pancreatic cancer development, may be effective.